dbi-002
Cell therapyexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Mar 16, 2021 (NCT04937920)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05491603 | Phase 2 | Oct 31, 2022 | DermBiont, Inc. |
| NCT05493488 | Phase 2 | Sep 8, 2022 | DermBiont, Inc. |
| NCT04937920 | Phase 2 | Mar 16, 2021 | DermBiont, Inc., Zepeda Dermatologia |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| DermBiont, Inc. | For profit | 3 | 3 | 1 | 2021 |
| Zepeda Dermatologia | Academic/Hospital | 1 | 0 | 1 | 2021 |
2 organizations
Page 1 / 1